Sedivention, a startup developing a novel weight-loss therapy designed to reduce hunger without implants, surgery, or lifelong drug intake, has closed a $3.4M seed funding round. The company, which promotes its approach as "Freezing the hunger feeling," secured investment from bmp Ventures, IBG funds, Cambridge Ventures, and HTGF | High-Tech Gründerfonds.
Sedivention's 20-minute treatment aims to offer a fast, effective, and long-term solution to fight obesity at its source.















